Drug Recognition Evaluation and Chemical Confirmation of a 25C-NBOMe-Impaired Driver - PubMed (original) (raw)
Case Reports
. 2017 Sep;62(5):1410-1413.
doi: 10.1111/1556-4029.13433. Epub 2017 Mar 6.
Affiliations
- PMID: 28261791
- DOI: 10.1111/1556-4029.13433
Case Reports
Drug Recognition Evaluation and Chemical Confirmation of a 25C-NBOMe-Impaired Driver
James W Rajotte et al. J Forensic Sci. 2017 Sep.
Abstract
This case report details an individual arrested for drug-impaired driving after leaving the scene of multiple motor vehicle collisions and evading police. The driver was examined by a drug recognition expert and failed the drug recognition evaluation. The driver admitted to using cocaine, marijuana, an antidepressant medication and "N-bomb," a novel psychoactive substance that possesses hallucinogenic properties. Toxicological analyses at the Centre of Forensic Sciences' Toronto laboratory revealed only the substance 2-[4-chloro-2,5-dimethoxyphenyl]-N-[(2-methoxyphenyl)methyl]ethanamine (25C-NBOMe) in the accused's urine. This is the first report in which 25C-NBOMe was identified through DRE and toxicological analyses in a drug-impaired driver.
Keywords: NBOMe; drug evaluation and classification program; drug recognition evaluator; drug-impaired driving; forensic science; novel psychoactive substances.
© 2017 American Academy of Forensic Sciences.
Similar articles
- 25C-NBOMe and 25I-NBOMe metabolite studies in human hepatocytes, in vivo mouse and human urine with high-resolution mass spectrometry.
Wohlfarth A, Roman M, Andersson M, Kugelberg FC, Diao X, Carlier J, Eriksson C, Wu X, Konradsson P, Josefsson M, Huestis MA, Kronstrand R. Wohlfarth A, et al. Drug Test Anal. 2017 May;9(5):680-698. doi: 10.1002/dta.2044. Epub 2016 Aug 12. Drug Test Anal. 2017. PMID: 27448631 - A fatal poisoning involving 25C-NBOMe.
Andreasen MF, Telving R, Rosendal I, Eg MB, Hasselstrøm JB, Andersen LV. Andreasen MF, et al. Forensic Sci Int. 2015 Jun;251:e1-8. doi: 10.1016/j.forsciint.2015.03.012. Epub 2015 Mar 24. Forensic Sci Int. 2015. PMID: 25841303 - 25C-NBOMe: preliminary data on pharmacology, psychoactive effects, and toxicity of a new potent and dangerous hallucinogenic drug.
Bersani FS, Corazza O, Albano G, Valeriani G, Santacroce R, Bolzan Mariotti Posocco F, Cinosi E, Simonato P, Martinotti G, Bersani G, Schifano F. Bersani FS, et al. Biomed Res Int. 2014;2014:734749. doi: 10.1155/2014/734749. Epub 2014 Jul 3. Biomed Res Int. 2014. PMID: 25105138 Free PMC article. Review. - NBOMe: new potent hallucinogens--pharmacology, analytical methods, toxicities, fatalities: a review.
Kyriakou C, Marinelli E, Frati P, Santurro A, Afxentiou M, Zaami S, Busardo FP. Kyriakou C, et al. Eur Rev Med Pharmacol Sci. 2015 Sep;19(17):3270-81. Eur Rev Med Pharmacol Sci. 2015. PMID: 26400534 Review.
Cited by
- 25C-NBOMe, a Novel Designer Psychedelic, Induces Neurotoxicity 50 Times More Potent Than Methamphetamine In Vitro.
Xu P, Qiu Q, Li H, Yan S, Yang M, Naman CB, Wang Y, Zhou W, Shen H, Cui W. Xu P, et al. Neurotox Res. 2019 May;35(4):993-998. doi: 10.1007/s12640-019-0012-x. Epub 2019 Feb 26. Neurotox Res. 2019. PMID: 30806983 - Effect of -NBOMe Compounds on Sensorimotor, Motor, and Prepulse Inhibition Responses in Mice in Comparison With the 2C Analogs and Lysergic Acid Diethylamide: From Preclinical Evidence to Forensic Implication in Driving Under the Influence of Drugs.
Tirri M, Bilel S, Arfè R, Corli G, Marchetti B, Bernardi T, Boccuto F, Serpelloni G, Botrè F, De-Giorgio F, Golembiowska K, Marti M. Tirri M, et al. Front Psychiatry. 2022 Apr 21;13:875722. doi: 10.3389/fpsyt.2022.875722. eCollection 2022. Front Psychiatry. 2022. PMID: 35530025 Free PMC article. - Pharmaco-Toxicological Effects of Atypical Synthetic Cathinone Mephtetramine (MTTA) in Mice: Possible Reasons for Its Brief Appearance over NPSs Scene.
Corli G, Tirri M, Arfè R, Marchetti B, Bernardi T, Borsari M, Odoardi S, Mestria S, Strano-Rossi S, Neri M, Gaudio RM, Bilel S, Marti M. Corli G, et al. Brain Sci. 2023 Jan 18;13(2):161. doi: 10.3390/brainsci13020161. Brain Sci. 2023. PMID: 36831704 Free PMC article. - Neurochemical and Behavioral Profiling in Male and Female Rats of the Psychedelic Agent 25I-NBOMe.
Miliano C, Marti M, Pintori N, Castelli MP, Tirri M, Arfè R, De Luca MA. Miliano C, et al. Front Pharmacol. 2019 Dec 12;10:1406. doi: 10.3389/fphar.2019.01406. eCollection 2019. Front Pharmacol. 2019. PMID: 31915427 Free PMC article. - NBOMes-Highly Potent and Toxic Alternatives of LSD.
Zawilska JB, Kacela M, Adamowicz P. Zawilska JB, et al. Front Neurosci. 2020 Feb 26;14:78. doi: 10.3389/fnins.2020.00078. eCollection 2020. Front Neurosci. 2020. PMID: 32174803 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical